This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

		Start the program at the bottom of this page

Embracing Opportunities to Overcome Challenges When Managing Pain in Older Adults Release Date: January-30-12 Credit Expiration Date: January-29-13 . Senior care pharmacists and others interested in the management of pain in older adults. Pharmacists: 0.75 Contact Hour (0.075 CEU) Online Presentation Most older adults experience pain that can interfere with normal functioning. This chronic pain increases the risk of depression, sleep problems, and hospitalization--and contributes negatively to patient quality of life and quality of care. The fact is, older adults who suffer from chronic and breakthrough pain often do not receive adequate pain control. This activity addresses the numerous barriers that interfere with the ability of clinicians to provide adequate pain management for patients, including regulatory and reimbursement issues, patient comorbidities, concern about side effects, poor medication adherence, and the cognitive issues and dementia many of these patients experience. By improving their knowledge, confidence, and skills, senior care pharmacists have the opportunity to help the entire care team improve pain management in the older patient population. Upon completion of this educational activity, the participant should be able to: 1. Review the pathophysiology of different types of pain that are common in the older patient population. 2. Describe how pain management strategies should be tailored based on the type of pain. 3. Develop policies and programs that can be implemented in the LTC setting to improve the management of pain. 4. Outline ways to improve pain management in older adults who have cognitive impairment and/or dementia. Kerry W. Cranmer, MD, CMD, FAAHPM CEO, Geriatric Medical Services Medical Director Progressive Care Center & Palliative Care Team Deaconess Hospital Oklahoma City, OK Janice M. Scheufler, PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Cleveland, OH It is the policy of the ASCP to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations. Dr. Cranmer discloses that he is on the speakers bureau for Lilly, Eiasi, Pfizer, and Purdue. Dr. Scheufler has no relevant financial conflicts to disclose. MCM: Dr. Joseph Kim has no relevant financial conflicts to disclose. Ms. Anne Jacobsen has no relevant financial conflicts to disclose. This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This knowledge-based activity, ACPE Universal Activity #0203-9999-12-020-H01-P,has been assigned 0.75 Contact Hour (0.075 CEU). Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 75% or better, and a statement may be printed immediately after passing the post-test. There is no fee to participate in this educational activity. This activity is supported by an educational grant from Purdue Pharma LP. Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers 1. Please turn off all pop-up blockers to assure access to the educational activity. 2. Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen. 3. The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 45 minutes to complete. 4. After the activity has finished, click on the "Post-test" button. 5. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. $0.00 © 2012, Medical Communications Media, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, and ASCP. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.